These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 3147010

  • 21. Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern.
    Valerio A, Basso D, Mazza S, Baldo G, Tiengo A, Pedrazzoli S, Seraglia R, Plebani M.
    Rapid Commun Mass Spectrom; 2001; 15(24):2420-5. PubMed ID: 11746913
    [Abstract] [Full Text] [Related]

  • 22. Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis.
    Ebert M, Schandl L, Schmid RM.
    Dig Dis; 2001; 19(1):32-6. PubMed ID: 11385249
    [Abstract] [Full Text] [Related]

  • 23. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma?
    Rabitti PG, Pacelli L, Uomo G, Laccetti M, Spada OA, Esposito G, Visconti M.
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):101-3. PubMed ID: 7948318
    [Abstract] [Full Text] [Related]

  • 24. [Diagnosis of pancreatic diseases by serum enzymes].
    Hayakawa T, Kondo T, Shibata T, Kitagawa M.
    Rinsho Byori; 1991 Jun; Suppl 89():35-48. PubMed ID: 1895518
    [No Abstract] [Full Text] [Related]

  • 25. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P, Zou M, Wen X, Gu F, Li J, Liu G, Dong J, Deng X, Gao J, Li X, Jia X, Dong Z, Chen L, Wang Y, Tian Y.
    Int J Cancer; 2014 Jun 01; 134(11):2646-55. PubMed ID: 24615168
    [Abstract] [Full Text] [Related]

  • 26. Low serum testosterone concentrations in patients with carcinoma of the pancreas.
    Greenway B, Iqbal MJ, Johnson PJ, Williams R.
    Br Med J (Clin Res Ed); 1983 Jan 08; 286(6359):93-5. PubMed ID: 6401508
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serum ferritin in pancreatic disease. An accurate test of malignancy?
    Nitti D, Fabris C, Del Favero G, Farini R, Grassi F, Farini A, Baccaglini U, Pedrazzoli S, Piccoli A, Lise M, Naccarato R.
    Digestion; 1982 Jan 08; 25(4):258-62. PubMed ID: 7166209
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Novel tumour markers: a diagnostic role in pancreatic cancer?
    Roulston JE.
    Br J Cancer; 1994 Sep 08; 70(3):389-90. PubMed ID: 8080718
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S.
    Ital J Gastroenterol; 1994 May 08; 26(4):169-73. PubMed ID: 7949259
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Blood CA 19-9 in the diagnosis of carcinoma of the pancreas: a critical approach].
    Angonese C, Basso D, Del Favero G, Fabris C, Tremolada C, Plebani M, Burlina A, Naccarato R.
    Ann Ital Med Int; 1987 May 08; 2(2):138-42. PubMed ID: 3275279
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.